stocktrader

SolarEdge stock plunge: Bargain buy or falling knife?

SolarEdge Technologies (NASDAQ: SEDG) is making headlines today with two significant pieces of news that have sent shockwaves through the market. The company announced plans for a private placement of $300 million in convertible senior notes, which will mature in 2029. This move aims to fund capped call transactions, redeem part of their outstanding 0%… Continue reading SolarEdge stock plunge: Bargain buy or falling knife?

FET, INJ soar up to 20% as Injective announces plans to collaborate with Fetch.ai

Fetch.ai (FET) and Injective (INJ) defied the current bearish markets with significant price increases over the past day. Monday’s X post from Injective about “something brewing” with Fetch.ai catalyzed recoveries for the altcoins within the last 24 hours. Something is brewing…$FET $INJ pic.twitter.com/mQdYoZIIfT — Injective 🥷 (@injective) June 24, 2024 Injective’s post feature the company’s… Continue reading FET, INJ soar up to 20% as Injective announces plans to collaborate with Fetch.ai

Standard Chartered set to offer direct BTC and ETH trading in London

Standard Chartered is set to launch a spot trading desk for buying and selling bitcoin and ETH, according to a report by Bloomberg on Friday. This new initiative will be based in London and will operate as part of the bank’s foreign exchange (FX) trading unit. By entering the spot cryptocurrency trading market, Standard Chartered… Continue reading Standard Chartered set to offer direct BTC and ETH trading in London

Citi hikes target price on Microsoft stock to $520: Can it reach there?

On Friday, analysts at Citi increased their target price on Microsoft Corp (NASDAQ:MSFT) from $495 to $520, while reiterating their ‘Buy’ rating. This upward revision underscores Citi’s confidence in Microsoft’s growth prospects, particularly fueled by its strategic investments in artificial intelligence (AI) and its dominant position in the tech industry. Dominance in the AI race… Continue reading Citi hikes target price on Microsoft stock to $520: Can it reach there?

Zealand Pharma stock rallies 20%: what happened?

Zealand Pharma (CPH: ZEAL) rallied more than 20% this morning after reporting positive results from an early stage trial of its new weight loss treatment.  The biotech firm is now trading at an all-time high.  Why is it significant for Zealand Pharma stock? Petrelintide – a long-acting amylin analog of Zealand Pharma showed significant efficacy… Continue reading Zealand Pharma stock rallies 20%: what happened?

Fossil fuels consumption hit record highs in 2023, Energy Institute reveals

In 2023, total fossil fuel consumption reached a record high worldwide, the Energy Institute (EI) reported yesterday. Published in the 73rd annual Statistical Review of World Energy report by the EI (along with co-authors KPMG and Kearney), the release presented the first full global energy data for 2023. It stated that 2023 was a year… Continue reading Fossil fuels consumption hit record highs in 2023, Energy Institute reveals

What’s going on with KKR stock?

In May, shares of KKR (NYSE: KKR) increased by 10.5%, driven by the company’s first-quarter results and several strategic partnerships. According to S&P Global Market Intelligence, KKR reported notable financial performance and expanded its investment footprint through various collaborations. KKR’s first-quarter earnings report reveals significant growth KKR reported strong first-quarter results in early May, highlighting… Continue reading What’s going on with KKR stock?